Press release

dsm-firmenich issues €800 million long-term bond

Kaiseraugst (Switzerland), Maastricht (Netherlands), June 26, 2024

dsm-firmenich today announces the successful launch of its inaugural €800 million bond with a ten-year maturity due in 2034, at a coupon of 3.625%. The bond will be issued by DSM B.V. and will be guaranteed by DSM-Firmenich AG pursuant to the recently established cross-guarantee structure.

The proceeds of the new bond will be used for general corporate purposes, including the refinancing of existing indebtedness.

The terms are laid down in the €8 billion Debt Issuance Program of dsm-firmenich alongside the Final Terms of this issuance, both of which are available here.

The re-offer price for the ten-year bond tranche was 99.456%. Based on this price, the yield is 3.691%. The bonds will shortly be listed on the Luxembourg Stock Exchange.

DSM-Firmenich AG is rated A3 (stable outlook) by Moody’s and A- (stable outlook) by S&P.

For more information:

Media relations:

Investor relations:

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.



This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction. This communication is not for release, distribution or publication, whether directly or indirectly and whether in whole or in part, into or in the United States of America or any (other) jurisdiction where any of such activities would constitute a violation of the relevant laws of such jurisdiction.

The offer of bonds referred to in this communication was limited in the EEA and the United Kingdom to qualified investors only. The bonds have not been and will not be registered under the US Securities Act of 1933, as amended (the “US Securities Act”) and will also not be registered with any authority competent with respect to securities in any state or other jurisdiction of the United States of America. The bonds may not be offered or sold in the United States of America without either registration of the securities or an exemption from registration under the US Securities Act being applicable.

The English language version of this press release prevails over other language versions.


Forward-looking statements

This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.